COMMUNIQUÉS West-GlobeNewswire

Applied Therapeutics Reports Second Quarter 2019 Financial Results
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today [...]
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
12/08/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Kane Biotech Strengthens Team with New Additions in Animal Health and Quality Assurance
12/08/2019
WINNIPEG, Manitoba, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Acacia Pharma Group plc: Notice of Interim Results
12/08/2019
Cambridge, UK and Indianapolis, US – 12 August 2019: Acacia Pharma Group plc (“Acacia Pharma”, the "Company”, the “Group”), (EURONEXT: ACPH), a pharmaceutical company developing and commercialising hospital products for [...]
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
12/08/2019
Reported that NYX-2925 met primary and secondary endpoints in Phase 2 fibromyalgia study On track to initiate three additional Phase 2 studies in 2H 2019 across pipeline of CNS product candidates Conference call today [...]
Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
12/08/2019
- Successful IPO provides more than $100 million in gross proceeds to advance leading oral integrin development pipeline and MInT discovery platform - Company remains on track to file INDs for its two lead programs [...]
BriaCell Appoints Richard J. Berman to Board of Directors
12/08/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Mesoblast Appoints Leading Pharmaceutical Industry Executive as Chief Medical Officer
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, is pleased to announce the appointment of Dr Fred Grossman as Chief [...]
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
12/08/2019
Sunnyvale, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has been approved by a leading Medicare Administrative Contractor (MAC) on behalf of the [...]
Transactions under Novozymes’ stock buyback program
12/08/2019
Please read the full announcement in the attached PDF Attachment 2019_30_Stock_Buybackprogram_EN
Share buy-back week 32/2019
12/08/2019
Announcement 12 August 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Aino Health interim report January-June 2019
12/08/2019
12 August 2019 Aino Health interim report January-June 2019 - Increased net sales, improved profit, net sales and cash flow, the business model is showing results April–June 2019 • Net sales increased by 18 percent to [...]
In July revenues increased by 14%, significant growth in all the main markets
12/08/2019
JSC Olainfarm preliminary consolidated results for July 2019 indicate that revenues increased by 14% compared to the same month last year and reached 9.5 million euro. At the same time consolidated results for the first [...]
Notice of Nexstim Plc's Half-Yearly Report H1 2019
12/08/2019
Company announcement, Helsinki, 12 August 2019 at 9.00 am (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), the targeted neuromodulation company developing and marketing pioneering navigated [...]
Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
12/08/2019
Investment bank supports Curetis in assessment of all strategic and tactical financing options Publication of H1-2019 financials postponed to September 18, 2019 Key financials show EUR 7.8 million cash as of June 30, [...]
Abeona Therapeutics annonce ses résultats financiers et mises à jour du deuxième trimestre 2019
10/08/2019
• Cinq patients atteints de la MPS IIIB traités dans le cadre de l'étude Transpher B sur la thérapie génique ABO-101 • Des résultats intermédiaires positifs sur la MPS IIIA ont montré une conservation du développement [...]
AgraFlora Organics Announces Issuance of Securities Pursuant to Debt Settlements
10/08/2019
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
AgraFlora Organics International Inc. annonce son intention de lancer une offre publique visant l’achat d’Eviana Health Corporation
10/08/2019
L’offre évaluée à 0,50 $ CA par action d’Eviana représente une prime de 49,25% par rapport au prix de clôture d’Eviana le 9 août 2019 VANCOUVER, Colombie-Britannique, 09 août 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics [...]
AgraFlora Organics International Inc. Announces Intention to Launch Takeover Bid for Eviana Health Corporation
09/08/2019
Offer valued at C$0.50 per Eviana share 49.25% premium to Eviana’s closing price on August 9, 2019 VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or [...]

Pages